The Growth of Private Plans in Medicare, 2006 February 28, 2006 Issue Brief , details the different types of private plan options available to people on Medicare. These include Medicare Advantage plans (such as Medicare HMOs, PPOs and private fee-for-service plans) and new stand-alone prescription drug plans.• In 2006, all Medicare beneficiaries have access to at least one type of private Medicare Advantage…
Chartpack: Selected Findings on Seniors’ Views of the Medicare Prescription Drug Benefit January 31, 2006 Poll Finding Chartpack: Selected Findings on Seniors’ Views of the Medicare Prescription Drug BenefitThese charts highlight key data from the February 2006 tracking poll on seniors’ views toward the new Medicare drug benefit.Chartpack (.pdf)
Medicare Part D Prescription Drug Plan Availability in 2013 November 19, 2012 Fact Sheet This fact sheet contains 2013 state-specific summary data about available Medicare drug benefit options, including premium ranges and the number of plans available at no cost to qualifying beneficiaries. Fact Sheet (.pdf)
Health Care Costs Survey – Summary and Chartpack August 30, 2005 Poll Finding The summary and chartpack highlight key findings from the joint USA Today/Kaiser/Harvard School of Public Health survey exploring Americans’ views on health care costs.Survey Summary and Chartpack (.pdf)
Women and Health Care: A National Profile June 29, 2005 Report A new national survey of women on their health finds that a substantial percentage of women cannot afford to go to the doctor or get prescriptions filled. Although a majority of women are in good health and satisfied with their health care, many have health problems and do not get…
Summary of Final Regulations Implementing the New Medicare Prescription Drug Benefit January 31, 2005 Issue Brief This document summarizes the final regulations to implement the new Medicare prescription drug benefit. The regulations were published by the Centers for Medicare and Medicaid Services (CMS) as a final rule in the Jan. 28 Federal Register. It provides an overview that allows interested parties to obtain information about specific…
Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Director – Report January 1, 2005 Report Implications of The Medicare Modernization Act For States: Observations from a Focus Group Discussion with Medicaid DirectorsThis report summarizes a discussion with a group of state Medicaid officials about the impact of the Medicare prescription drug benefit on state Medicaid programs. Report (.pdf)
Marketing and Privacy Issues: An Analysis of the MMA and Proposed Regulations September 2, 2004 Issue Brief This paper, by Joy Pritts of the Health Policy Institute at Georgetown University, looks at issues related to drug plan marketing activities and privacy under the MMA.Issue Brief (.pdf)
Grievance and Appeals Procedures: An Analysis of the MMA and Proposed Regulations September 1, 2004 Issue Brief This paper, by Sara Rosenbaum, J.D., Director of the Center for Health Services Research and Policy at George Washington University, examines the procedures for resolving beneficiaries' grievances and appeals under the new Medicare drug benefit. It is one in a series commissioned by the Kaiser Family Foundation that analyzes issues…
Selected Findings on Knowledge and Understanding of the New Medicare Rx Drug Program — May/June 2004 Kaiser Health Poll Report Survey June 30, 2004 Poll Finding Topline findings from the May/June 2004 Kaiser Health Poll Report survey, including knowledge and opinions about the new Medicare prescription drug law.Survey Toplines (.pdf)